Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsFenofibrate

    Fenofibrate

    Jump to

    • Glenmark gets USFDA nod for anti-cholesterol drug

      The company has been granted final approval by the United States Food and Drug Administration (USFDA) for Fenofibrate Capsules USP, 67 mg, 134 mg and 200 mg, Glenmark Pharmaceuticals said in a statement.

    • Lupin gets USFDA nod for cholesterol drug

      The company has received final approval from the US Food and Drug Administration (USFDA) to market generic version of Teva's Fenofibrate tablets in strengths of 54mg and 160mg, Lupin said in a statement.

    • Lupin up 8% on USFDA nod for cholesterol drug from Goa unit

      Brokerage firm Citi says the US FDA approval of cholesterol drug Fenofibrate is positive as it is filed from its Goa plant and it vindicates management commentary that the observations received by the regulator in July are not disruptive.

    • About 30% products will be impacted by price control: Lupin

      Mumbai based pharma company Lupin says any kind of price control will be a deterrent for the industry and 30 percent of its portfolio will be impacted if government implements price control measures.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347